Stockholders’ Deficit - Schedule of Stock Options Roll Forward (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		12 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Jan. 31, 2024
Number of Options
Outstanding, beginning of period (in shares)	3,185,020
Granted (in shares)	8,000,000
Exercised (in shares)	(641,537)
Cancelled (in shares)	(1,500)
Outstanding, end of period (in shares)	10,541,983		3,185,020
Options vested, number of options (in shares)	2,429,487
Options exercisable, number of options (in shares)	2,429,487
Weighted- Average Exercise Price
Outstanding, beginning of period (in USD per share)	$ 6.23
Granted (in USD per share)	32.00
Exercised (in USD per share)	5.64
Cancelled (in USD per share)	7.99
Outstanding, end of period (in USD per share)	25.82		$ 6.23
Options vested, weighted average exercise price per share (in USD per share)	5.76
Options exercisable, weighted average exercise price per share (in USD per share)	$ 5.76
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]
Options outstanding, weighted average remaining contractual term	8 years 6 months		4 years 2 months 12 days
Options vested, weighted average remaining contractual term	3 years 9 months 18 days
Options exercisable, weighted average remaining contractual term	3 years 9 months 18 days
Options outstanding, aggregate intrinsic value	$ 65,344		$ 71,347
Options exercised, aggregate intrinsic value	16,455	$ 6,500
Options exercisable, aggregate intrinsic value	63,805
Options vested, aggregate intrinsic value	$ 63,805